Synlogic, Inc. SEC filings SYBX
Synlogic, Inc. has 627 filings in SEC EDGAR's recent list, going back to Aug 23, 2011. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 29, 2026 (material agreement, change to shareholder rights, change in control, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Nov 12, 2025 | Dec 15, 2025 |
| DEF 14A | Proxy statement | Nov 6, 2024 | Dec 4, 2024 |
| DEF 14A | Proxy statement | Sep 1, 2023 | Sep 21, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 21, 2023 | Sep 21, 2023 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 15, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 21, 2023 | Jun 15, 2023 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 9, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2021 | — |
| DEF 14A | Proxy statement | Apr 27, 2021 | Jun 10, 2021 |
| DEFA14A | Additional proxy material | Apr 17, 2020 | — |
| DEF 14A | Proxy statement | Apr 17, 2020 | Jun 4, 2020 |
| DEF 14A | Proxy statement | Apr 18, 2019 | Jun 5, 2019 |
| DEFA14A | Additional proxy material | May 15, 2018 | — |
| DEF 14A | Proxy statement | Apr 27, 2018 | Jun 13, 2018 |
| DEFA14A | Additional proxy material | Apr 27, 2016 | — |
| DEF 14A | Proxy statement | Apr 27, 2016 | Jun 29, 2016 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SYBX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Winchester, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1527599
- Former names
- Mirna Therapeutics, Inc. (until Aug 25, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.